RenovoRx Inc. (RNXT)
0.99
-0.01 (-0.99%)
At close: Mar 03, 2025, 11:42 AM
RenovoRx Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 1.17M | 6.44M | 15.19M | 1.79M | 2.1M |
| Short-Term Investments | n/a | 2.05M | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | n/a | n/a | n/a | 4K | 4K |
| Receivables | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 293K | 825K | 1.09M | 115K | 162K |
| Total Current Assets | 1.47M | 7.26M | 16.28M | 1.91M | 2.27M |
| Property-Plant & Equipment | n/a | n/a | 6K | n/a | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | n/a | n/a | 6K | 4K | 4K |
| Total Assets | 1.47M | 7.26M | 16.29M | 1.91M | 2.27M |
| Account Payables | 561K | 534K | 525K | 162K | 538K |
| Deferred Revenue | n/a | n/a | n/a | 311K | n/a |
| Short-Term Debt | n/a | n/a | n/a | 2.77M | n/a |
| Other Current Liabilities | 614K | 568K | 413K | 1.17M | 267K |
| Total Current Liabilities | 1.18M | 1.1M | 938K | 4.1M | 805K |
| Long-Term Debt | n/a | n/a | n/a | 23K | n/a |
| Other Long-Term Liabilities | 3.29M | n/a | n/a | 12.45M | n/a |
| Total Long-Term Liabilities | 3.29M | 568K | n/a | 12.47M | 12.39M |
| Total Liabilities | 4.47M | 1.1M | 938K | 16.57M | 13.2M |
| Total Debt | n/a | n/a | n/a | 2.79M | 12.39M |
| Common Stock | 1K | 1K | 1K | 1K | 1K |
| Retained Earnings | -41.41M | -31.17M | -21.28M | -14.96M | -11.16M |
| Comprehensive Income | n/a | 17K | -16.29M | -12.45K | -12.39K |
| Shareholders Equity | -3M | 6.16M | 15.35M | -14.66M | -10.93M |
| Total Investments | n/a | 2.05M | n/a | n/a | n/a |